As Insulet Corp (PODD) Market Value Rose, Fred Alger Management INC Decreased Its Holding by $4.28 Million

0

Insulet Corporation (NASDAQ:PODD) LogoInvestors sentiment increased to 1.12 in 2018 Q4. Its up 0.17, from 0.95 in 2018Q3. It is positive, as 28 investors sold PODD shares while 63 reduced holdings. 28 funds opened positions while 74 raised stakes. 63.61 million shares or 2.13% more from 62.28 million shares in 2018Q3 were reported. Citigroup Incorporated accumulated 28,268 shares. Pier Limited Liability Com reported 1.24% of its portfolio in Insulet Corporation (NASDAQ:PODD). State Board Of Administration Of Florida Retirement Systems reported 78,407 shares stake. Susquehanna Group Llp owns 0% invested in Insulet Corporation (NASDAQ:PODD) for 27,213 shares. Bnp Paribas Arbitrage Sa invested in 0% or 3,302 shares. Principal Financial Group Inc has 13,437 shares. 68,711 are owned by Pdts Partners Limited Co. Illinois-based Segall Bryant & Hamill Ltd Co has invested 0.19% in Insulet Corporation (NASDAQ:PODD). Clearbridge Ltd accumulated 1.88 million shares. Stephens Management Ltd Llc has 0.2% invested in Insulet Corporation (NASDAQ:PODD) for 108,033 shares. Blair William And Il has 0.01% invested in Insulet Corporation (NASDAQ:PODD). Geode Cap Mngmt accumulated 0.01% or 587,079 shares. Jennison Associates Ltd Com invested in 82,820 shares. Portfolio Solutions Ltd Liability Corp reported 0% of its portfolio in Insulet Corporation (NASDAQ:PODD). Victory Mngmt holds 0.07% of its portfolio in Insulet Corporation (NASDAQ:PODD) for 360,570 shares.

Since November 1, 2018, it had 0 insider buys, and 5 selling transactions for $1.58 million activity. Shares for $98,556 were sold by Petrovic Shacey. The insider Abdel-Malek Aiman sold 602 shares worth $48,407.

Fred Alger Management Inc decreased its stake in Insulet Corp (PODD) by 3.18% based on its latest 2018Q4 regulatory filing with the SEC. Fred Alger Management Inc sold 54,233 shares as the company’s stock rose 9.83% with the market. The institutional investor held 1.65M shares of the medical and dental instruments company at the end of 2018Q4, valued at $131.00 million, down from 1.71 million at the end of the previous reported quarter. Fred Alger Management Inc who had been investing in Insulet Corp for a number of months, seems to be less bullish one the $5.57B market cap company. It closed at $93.35 lastly. It is down 26.95% since April 15, 2018 and is uptrending. It has outperformed by 22.58% the S&P500.

Fred Alger Management Inc, which manages about $21.12B and $21.72B US Long portfolio, upped its stake in Walt Disney Co. (NYSE:DIS) by 1.32M shares to 2.29M shares, valued at $251.52 million in 2018Q4, according to the filing. It also increased its holding in Bio (NASDAQ:TECH) by 123,255 shares in the quarter, for a total of 813,436 shares, and has risen its stake in Gw Pharmaceuticals Adr (NASDAQ:GWPH).

Analysts await Insulet Corporation (NASDAQ:PODD) to report earnings on May, 2. They expect $0.02 earnings per share, up 118.18 % or $0.13 from last year’s $-0.11 per share. PODD’s profit will be $1.19M for 1166.88 P/E if the $0.02 EPS becomes a reality. After $0.16 actual earnings per share reported by Insulet Corporation for the previous quarter, Wall Street now forecasts -87.50 % negative EPS growth.

Insulet Corporation (NASDAQ:PODD) Ratings Coverage

Among 6 analysts covering Insulet (NASDAQ:PODD), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Insulet had 10 analyst reports since November 28, 2018 according to SRatingsIntel. The stock of Insulet Corporation (NASDAQ:PODD) earned “Buy” rating by Northland Capital on Tuesday, February 26. The stock has “Buy” rating by Canaccord Genuity on Tuesday, February 19. Morgan Stanley maintained the stock with “Equal-Weight” rating in Wednesday, January 2 report. As per Tuesday, February 26, the company rating was maintained by Oppenheimer. The company was maintained on Tuesday, February 26 by Robert W. Baird.

Insulet Corporation (NASDAQ:PODD) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.